Dallah Healthcare Company reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was SAR 600.89 million compared to SAR 544.12 million a year ago. Net income was SAR 43.87 million compared to SAR 49.85 million a year ago. Basic earnings per share from continuing operations was SAR 0.49 compared to SAR 0.55 a year ago.
For the nine months, sales was SAR 1,794.11 million compared to SAR 1,529.61 million a year ago. Net income was SAR 196.02 million compared to SAR 150 million a year ago. Basic earnings per share from continuing operations was SAR 2.18 compared to SAR 1.67 a year ago.